Association of serum vitamin D and parathyroid hormone with subclinical atherosclerotic phenotypes: The Dong-gu Study

PLoS ONE

Volumn 12, Issue 10, 2017, Pages

  Lee, Young Hoon ^a,b   Kweon, Sun Seog ^c,d   Choi, Jin Su ^c   Nam, Hae Sung ^e   Park, Kyeong Soo ^f   Choi, Seong Woo ^g   Ryu, So Yeon ^g   Oh, Su Hyun ^c   Shin, Min Ho ^c  

^a Wonkwang University School of Medicine   (South Korea)

^b Wonkwang University Hospital   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d Chonnam National University Research Institute of Medical Sciences   (South Korea)

^e Chungnam National University   (South Korea)

^f Seonam University   (South Korea)

^g Chosun University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE; VITAMIN D;

AGED; ARTERIAL WALL THICKNESS; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; B SCAN; CARDIOVASCULAR RISK; CAROTID ARTERY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PATIENT RISK; PHENOTYPE; PREVALENCE; PULSE WAVE; RISK FACTOR; VITAMIN BLOOD LEVEL; BLOOD; MIDDLE AGED; PATHOLOGY; SOUTH KOREA;

AGED; ATHEROSCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHENOTYPE; REPUBLIC OF KOREA; VITAMIN D;

EID: 85032966336     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0186421     Document Type: Article

References (47)

1. Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR, et al. Relationship of 25-hydro-xyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr. 2010; 64: 203–209. https://doi.org/10.1038/ejcn.2009.140 PMID: 19953106
2. Wang L, Song Y, Manson JE, Pilz S, März W, Michaëlsson K, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012; 5: 819–829. https://doi.org/10.1161/CIRCOUTCOMES.112.967604 PMID: 23149428
3. Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation. 2009; 119: 2765–2771. https://doi.org/10.1161/CIRCULATIONAHA.108.808733 PMID: 19451355
4. van Ballegooijen AJ, Reinders I, Visser M, Dekker JM, Nijpels G, Stehouwer CD, et al. Serum parathyroid hormone in relation to all-cause and cardiovascular mortality: the Hoorn study. J Clin Endocrinol Metab. 2013; 98: E638–645. https://doi.org/10.1210/jc.2012-4007 PMID: 23408568
5. Kestenbaum B, Katz R, de Boer I, Hoofnagle A, Sarnak MJ, Shlipak MG, et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol. 2011; 58: 1433–1441. https://doi.org/10.1016/j.jacc.2011.03.069 PMID: 21939825
6. Çelik G, Doğan A, Dener Ş, Öztürk Ş, Kulaksızoğlu S, Ekmekçi H. Parathyroid Hormone Levels in the Prediction of Ischemic Stroke Risk. Dis Markers. 2017; 2017: 4343171. https://doi.org/10.1155/2017/4343171 PMID: 28115793
7. Prati P, Tosetto A, Vanuzzo D, Bader G, Casaroli M, Canciani L, et al. Carotid intima media thickness and plaques can predict the occurrence of ischemic cerebrovascular events. Stroke. 2008; 39: 2470–2476. https://doi.org/10.1161/STROKEAHA.107.511584 PMID: 18617662
8. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007; 115: 459–467. https://doi.org/10.1161/CIRCULATIONAHA.106.628875 PMID: 17242284
9. Nambi V, Chambless L, He M, Folsom AR, Mosley T, Boerwinkle E, et al. Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study. Eur Heart J. 2012; 33: 183–190. https://doi.org/10.1093/eurheartj/ehr192 PMID: 21666250
10. Mannami T, Baba S, Ogata J. Potential of carotid enlargement as a useful indicator affected by high blood pressure in a large general population of a Japanese city: the Suita study. Stroke. 2000; 31: 2958–2965. PMID: 11108756
11. Baldassarre D, Hamsten A, Veglia F, de Faire U, Humphries SE, Smit AJ, et al. Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (Carotid Intima Media Thickness [IMT] and IMT-Progression as Predictors of Vascular Events in a High Risk European Population) study. J Am Coll Cardiol. 2012; 60: 1489–1499. https://doi.org/10.1016/j.jacc.2012.06.034 PMID: 22999719
12. Bots ML, Grobbee DE, Hofman A, Witteman JC. Common carotid intima-media thickness and risk of acute myocardial infarction: the role of lumen diameter. Stroke. 2005; 36: 762–767. https://doi.org/10.1161/01.STR.0000158924.71069.94 PMID: 15746451
13. Leone N, Ducimetière P, Gariépy J, Courbon D, Tzourio C, Dartigues JF, et al. Distension of the carotid artery and risk of coronary events: the three-city study. Arterioscler Thromb Vasc Biol. 2008; 28: 1392–1397. https://doi.org/10.1161/ATVBAHA.108.164582 PMID: 18421001
14. Tomiyama H, Koji Y, Yambe M, Shiina K, Motobe K, Yamada J, et al. Brachial-ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J. 2005; 69: 815–822. PMID: 15988107
15. Matsuoka O, Otsuka K, Murakami S, Hotta N, Yamanaka G, Kubo Y, et al. Arterial stiffness independently predicts cardiovascular events in an elderly community: Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) study. Biomed Pharmacother. 2005; 59 Suppl 1: S40–44.
16. Reis JP, von Mühlen D, Michos ED, Miller ER 3rd, Appel LJ, Araneta MR, et al. Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis. 2009; 207: 585–590. https://doi.org/10.1016/j.atherosclerosis.2009.05.030 PMID: 19539290
17. Carrelli AL, Walker MD, Lowe H, McMahon DJ, Rundek T, Sacco RL, et al. Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study. Stroke. 2011; 42: 2240–2245. https://doi.org/10.1161/STROKEAHA.110.608539 PMID: 21719770
18. Lim S, Shin H, Kim MJ, Ahn HY, Kang SM, Yoon JW, et al. Vitamin D inadequacy is associated with significant coronary artery stenosis in a community-based elderly cohort: the Korean Longitudinal Study on Health and Aging. J Clin Endocrinol Metab. 2012; 97: 169–178. https://doi.org/10.1210/jc.2011-1580 PMID: 22013101
19. Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol. 2011; 58: 186–192. https://doi.org/10.1016/j.jacc.2011.02.051 PMID: 21718915
20. Blondon M, Sachs M, Hoofnagle AN, Ix JH, Michos ED, Korcarz C, et al. 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2013; 33: 2639–2645. https://doi.org/10.1161/ATVBAHA.113.301781 PMID: 23814117
21. Knox S, Welsh P, Bezlyak V, McConnachie A, Boulton E, Deans KA, et al. 25-Hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: results from pSoBid. Atherosclerosis. 2012; 223: 437–441. https://doi.org/10.1016/j.atherosclerosis.2012.05.001 PMID: 22632919
22. Michos ED, Streeten EA, Ryan KA, Rampersaud E, Peyser PA, Bielak LF, et al. Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease or C-reactive protein in the old order Amish. Calcif Tissue Int. 2009; 84: 195–202. https://doi.org/10.1007/s00223-008-9209-3 PMID: 19148561
23. Choi HS, Kim SH, Rhee Y, Cho MA, Lee EJ, Lim SK. Serum parathyroid hormone is associated with carotid intima-media thickness in postmenopausal women. Int J Clin Pract. 2008; 62: 1352–1357. https://doi.org/10.1111/j.1742-1241.2008.01801.x PMID: 18657200
24. Kweon SS, Shin MH, Jeong SK, Nam HS, Lee YH, Park KS, et al. Cohort Profile: The Namwon Study and the Dong-gu Study. Int J Epidemiol. 2014; 43: 558–567. https://doi.org/10.1093/ije/dys244 PMID: 23505254
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130: 461–470. PMID: 10075613
26. Tomaschitz A, Ritz E, Pieske B, Fahrleitner-Pammer A, Kienreich K, Horina JH, et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res. 2012; 94: 10–19. https://doi.org/10.1093/cvr/cvs092 PMID: 22334595
27. Björkman M, Sorva A, Tilvis R. Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. Arch Gerontol Geriatr. 2009; 48: 160–166. https://doi.org/10.1016/j.archger.2007.12.005 PMID: 18243368
28. Qi L, Ma W, Heianza Y, Zheng Y, Wang T, Sun D, et al. Independent and synergistic associations of biomarkers of vitamin D status with risk of coronary heart disease. Arterioscler Thromb Vasc Biol. 2017 Sep 7. https://doi.org/10.1161/ATVBAHA.117.309548 PMID: 28882871
29. Veloudi P, Jones G, Sharman JE. Effectiveness of vitamin D supplementation for cardiovascular health outcomes. Pulse (Basel). 2017; 4: 193–207.
30. Brøndum-Jacobsen P, Benn M, Afzal S, Nordestgaard BG. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study. Int J Epidemiol. 2015; 44: 651–661. https://doi.org/10.1093/ije/dyv078 PMID: 25981321
31. Crouse JR, Goldbourt U, Evans G, Pinsky J, Sharrett AR, Sorlie P, et al. Arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort: in vivo quantification of carotid arterial enlargement. Stroke. 1994; 25: 1354–1359. PMID: 8023349
32. Labropoulos N, Zarge J, Mansour MA, Kang SS, Baker WH. Compensatory arterial enlargement is a common pathobiologic response in early atherosclerosis. Am J Surg. 1998; 176: 140–143. PMID: 9737619
33. Giallauria F, Milaneschi Y, Tanaka T, Maggio M, Canepa M, Elango P, et al. Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. J Clin Endocrinol Metab. 2012; 97: 3717–3723. https://doi.org/10.1210/jc.2012-1584 PMID: 22767638
34. Şeker T, Gür M, Kuloğlu O, Kalkan GY, Şahin DY, Türkoğlu C, et al. Serum 25-hydroxyvitamin D is associated with both arterial and ventricular stiffness in healthy subjects. J Cardiol. 2013; 62: 361–365. https://doi.org/10.1016/j.jjcc.2013.06.004 PMID: 23867332
35. Kuloğlu O, Gür M, Şeker T, Kalkan GY, Şahin DY, Tanboğa IH, et al. Serum 25-hydroxyvitamin D level is associated with arterial stiffness, left ventricle hypertrophy, and inflammation in newly diagnosed hypertension. J Investig Med. 2013; 61: 989–994. https://doi.org/10.2310/JIM.0b013e31829a82bc PMID: 23799341
36. Kruger IM, Kruger MC, Doak CM, Schutte AE, Huisman HW, Van Rooyen JM, et al. The association of 25(OH)D with blood pressure, pulse pressure and carotid-radial pulse wave velocity in African women. PLoS One. 2013; 8: e54554. https://doi.org/10.1371/journal.pone.0054554 PMID: 23355878
37. Pirro M, Manfredelli MR, Helou RS, Scarponi AM, Schillaci G, Bagaglia F, et al. Association of parathyroid hormone and 25-OH-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J Atheroscler Thromb. 2012; 19: 924–931. PMID: 22785083
38. Valcour A, Blocki F, Hawkins DM, Rao SD. Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels. J Clin Endocrinol Metab. 2012; 97: 3989–3995. https://doi.org/10.1210/jc.2012-2276 PMID: 22933544
39. Meng F, Wang W, Ma J, Lin B. Parathyroid hormone and risk of heart failure in the general population: A meta-analysis of prospective studies. Medicine (Baltimore). 2016; 95: e4810.
40. Lerstad G, Brodin EE, Svartberg J, Jorde R, Brox J, Brækkan SK, et al. Associations between serum levels of calcium, parathyroid hormone and future risk of venous thromboembolism: the Tromsø study. Eur J Endocrinol. 2017; 176: 625–634. https://doi.org/10.1530/EJE-16-1037 PMID: 28246149
41. Brown SJ, Ruppe MD, Tabatabai LS. The Parathyroid Gland and Heart Disease. Methodist Debakey Cardiovasc J. 2017; 13: 49–54. https://doi.org/10.14797/mdcj-13-2-49 PMID: 28740581
42. Bosworth C, Sachs MC, Duprez D, Hoofnagle AN, Ix JH, Jacobs DR Jr, et al. Parathyroid hormone and arterial dysfunction in the Multi-Ethnic Study of Atherosclerosis. Clin Endocrinol (Oxf). 2013; 79: 429–436.
43. Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci. 2009; 338:40–44. https://doi.org/10.1097/MAJ.0b013e3181aaee91 PMID: 19593102
44. Mozos I, Marginean O. Links between Vitamin D Deficiency and Cardiovascular Diseases. Biomed Res Int. 2015; 2015:109275. https://doi.org/10.1155/2015/109275 PMID: 26000280
45. Slominski AT, Li W, Kim TK, Semak I, Wang J, Zjawiony JK, et al. Novel activities of CYP11A1 and their potential physiological significance. J Steroid Biochem Mol Biol. 2015; 151: 25–37. https://doi.org/10.1016/j.jsbmb.2014.11.010 PMID: 25448732
46. Slominski AT, Kim TK, Li W, Tuckey RC. Classical and non-classical metabolic transformation of vitamin D in dermal fibroblasts. Exp Dermatol. 2016; 25: 231–232. https://doi.org/10.1111/exd.12872 PMID: 26440881
47. Slominski AT, Kim TK, Li W, Postlethwaite A, Tieu EW, Tang EK, et al. Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland. Sci Rep. 2015; 5: 14875. https://doi.org/10.1038/srep14875 PMID: 26445902